pharmaceuticals

The Golden Age of Doctor-Shopping

In 2012, right before prescription drug-monitoring programs (PDMP) shut everything down, I was seeing 11 doctors every month—the same 11…

April 29, 2025

Walgreens Settles DOJ Prescription Opioid Lawsuit, Likely at $350 Million

Walgreens, the nation’s second-largest pharmacy chain, will pay $300 million plus 4 percent interest to settle Department of Justice allegations…

April 22, 2025

Secret Shoppers Struggle to Buy Naloxone, Syringes at Texas Pharmacies

Since the Food and Drug Administration approved over-the-counter (OTC) naloxone in 2023, pharmacies nationwide have stocked their shelves with the…

March 25, 2025

BC Government’s Crackdown on Safe Supply Spreads Fear

British Columbia’s provincial government has ended its take-home safe supply program for new participants, with an intention to transition existing…

February 21, 2025

DOJ Sues CVS, Alleging “Massive Public Harm” From Opioid Dispensing

The Department of Justice is accusing CVS Pharmacy Inc. of unlawfully filling opioid prescriptions that directly led to overdose deaths,…

December 19, 2024

Pharmacists’ Opioid Decisions: From “Social Sorting” to Policing

[This article is excerpted from the book Policing Patients. You can read Filter’s interview with the author here.]   Pharmacists’…

December 12, 2024

How “Trojan Horse Technology” Turned Health Care Into Policing

Policing Patients: Treatment and Surveillance on the Frontlines of the Opioid Crisis is a Swiss Army knife of a book.…

December 12, 2024

Purdue Backs Fraud Claim Against Sacklers, Amid Scramble for Immunity

In bankruptcy court on July 9, OxyContin manufacturer Purdue Pharma secured an injunction to temporarily stave off lawsuits while it…

July 11, 2024

Walgreens Rolls Out $34.99 Naloxone, as Generics and OTC Gain Ground

Walgreens is rolling out an over-the-counter (OTC) naloxone nasal spray, which it will sell alongside the OTC Narcan it already…

May 16, 2024

The Opioid Settlements Being Paid in Naloxone Don’t Quite Add Up

Amneal Pharmaceuticals, a New Jersey-based manufacturer known for generics, has agreed to settle the 900-plus lawsuits alleging it failed to…

May 7, 2024